← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Riboscience, Llc
Palo Alto, CA
$6,275,848
Total funding
3
Grants
Funding over time
peak $2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,275,848 · 3
By mechanism
R44$5,969,109 · 2
R41$306,739 · 1
Investigators at Riboscience, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic$995,102
R44 · FY2021 · DA
Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic$995,102
R44 · FY2020 · DA
Advancing a novel potent double anti-HCV nucleoside analog combination treatment for the OUD population to the clinic$995,102
R44 · FY2019 · DA
Advancing a novel potent Zika virus specific nucleoside analog to the clinic$995,099
R44 · FY2018 · AI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic$995,099
R44 · FY2019 · AI
Advancing a novel potent Zika virus specific nucleoside analog to the clinic$993,605
R44 · FY2017 · AI
Inhibitors of ENPP1 for the treatment of hepatocellular carcinoma$306,739
R41 · FY2025 · CA